| Item Type | Name |
|
Academic Article
|
Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
|
|
Academic Article
|
Metabolic basis of HIV-lipodystrophy syndrome.
|
|
Academic Article
|
Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome.
|
|
Academic Article
|
Dysregulated energy expenditure in HIV-infected patients: a mechanistic review.
|
|
Academic Article
|
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy.
|
|
Academic Article
|
Fenofibrate is effective in treating hypertriglyceridemia associated with HIV lipodystrophy.
|
|
Academic Article
|
Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study.
|
|
Academic Article
|
Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.
|
|
Academic Article
|
Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome.
|
|
Academic Article
|
Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.
|
|
Academic Article
|
Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.
|
|
Academic Article
|
HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.
|
|
Academic Article
|
Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice.
|
|
Academic Article
|
HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution.
|
|
Academic Article
|
HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms.
|
|
Academic Article
|
Treatment of dyslipidemia in HIV-infected patients.
|
|
Academic Article
|
Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.
|
|
Academic Article
|
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia.
|
|
Academic Article
|
Human monocytes accelerate proliferation and blunt differentiation of preadipocytes in association with suppression of C/EBP? mRNA.
|
|
Academic Article
|
Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.
|
|
Concept
|
HIV Seropositivity
|
|
Concept
|
HIV Integrase
|
|
Concept
|
HIV-Associated Lipodystrophy Syndrome
|
|
Concept
|
HIV-1
|
|
Concept
|
HIV Integrase Inhibitors
|
|
Concept
|
HIV
|
|
Concept
|
HIV Infections
|
|
Concept
|
Anti-HIV Agents
|
|
Academic Article
|
Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.
|
|
Academic Article
|
Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART).
|
|
Academic Article
|
HIV-1 Vpr enhances PPAR?/d-mediated transcription, increases PDK4 expression, and reduces PDC activity.
|
|
Academic Article
|
HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation.
|
|
Academic Article
|
Human adipose tissue as a reservoir for memory CD4+ T cells and HIV.
|
|
Academic Article
|
Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner.
|
|
Academic Article
|
HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRa and PPARa dysregulation: implications for HIV-specific pathogenesis of NAFLD.
|
|
Academic Article
|
Adipocytes impair efficacy of antiretroviral therapy.
|
|
Grant
|
Viral mechanisms of adipocyte dysfuntion: Role of Vpr.
|
|
Grant
|
MOLECULAR BASIS OF HIV LIPODYSTROPHY: ROLE OF VPR
|
|
Grant
|
Adipose Tissue is a significant reservoir for HIV
|
|
Grant
|
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
|
|
Grant
|
Adipose Tissue is a significant reservoir for HIV
|
|
Academic Article
|
HIV-1 Viral Protein R Couples Metabolic Inflexibility With White Adipose Tissue Thermogenesis.
|
|
Academic Article
|
Heightened levels of plasma growth differentiation factor 15 in men living with HIV.
|
|
Academic Article
|
Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV.
|
|
Academic Article
|
Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV.
|